Pharmedium Recalls Phenylephrine Injection Due to Human Hair Contamination
Pharmedium Services, LLC is recalling specific lots of Phenylephrine HCl injection because the sodium chloride base used contained human hair.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
Pharmedium Services, LLC is recalling 240 bags of Phenylephrine HCl, 50 mg added to 250 mL 0.9% Sodium Chloride Injection USP. The product is packaged in 250 ml bags and is prescription-only. The recall covers three specific lots: 14310039S (Exp 11/06/14), 14318006S (Exp 11/17/14), and 14321060S (Exp 11/07/14).
The recall was initiated because the firm manufactured these products using Hospira 0.9% Sodium Chloride, USP injection, which was subsequently recalled due to the presence of particulate matter, specifically human hair. The affected products were distributed nationwide.
Healthcare providers and patients should check their inventory and medication records for the specific lot numbers and expiration dates listed above. If these products are found, they should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- PHENYLephrine HCl, 50 mg added to 250 mL 0.9% Sodium Chloride Injection USP (200 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX 77478, NDC# 61553-171-50
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Affected units
- 240
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 14310039S
- Exp 11/06/14
- 14318006S
- Exp 11/17/14
- 14321060S
- Exp11/07/14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Infusions Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- CriticalPharMEDium Recalls Epinephrine Injection Bags Due to Particulate Matter
FDA (Drugs) · 2015-09-02
- SeverePharmedium Recalls Phenylephrine HCl Injections Due To Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Phenylephrine Syringes Due to Potential Loss of Potency
FDA (Drugs) · 2016-10-19
- SeverePharmedium Recalls Phenylephrine Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-10-19
- CriticalPharMEDium Recalls Heparin Sodium Injection Bags Due to Particulate Matter
FDA (Drugs) · 2015-09-02
- SeverePharmedium Recalls Superpotent Phenylephrine Syringes Nationwide
FDA (Drugs) · 2018-01-24